AP
UTHR icon

Advisor Partners’s United Therapeutics UTHR Stock Holding History

Advisor Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$323K Buy
1,369
+110
+9% +$22.4K 0.02% 612
2022
Q1 		$226K Buy
1,259
+10
+0.8% +$1.91K 0.01% 775
2021
Q4 		$270K Buy
1,249
+53
+4% +$10.4K 0.02% 713
2021
Q3 		$221K Sell
1,196
-113
-9% -$22.3K 0.01% 737
2021
Q2 		$235K Buy
1,309
+25
+2% +$4.76K 0.02% 742
2021
Q1 		$215K Sell
1,284
-34
-3% -$5.67K 0.02% 750
2020
Q4 		$200K Buy
+1,318
New +$173K 0.02% 712
2018
Q4 		– Sell
-1,573
Closed -$201K – 664
2018
Q3 		$201K Buy
+1,573
New +$195K 0.03% 601
2018
Q1 		– Sell
-1,836
Closed -$256K – 604
2017
Q4 		$256K Buy
1,836
+17
+0.9% +$2.16K 0.05% 451
2017
Q3 		$213K Sell
1,819
-44
-2% -$5.62K 0.04% 445
2017
Q2 		$242K Sell
1,863
-127
-6% -$15.8K 0.06% 386
2017
Q1 		$269K Buy
1,990
+120
+6% +$18.2K 0.07% 344
2016
Q4 		$268K Buy
+1,870
New +$239K 0.08% 298
2016
Q1 		– Sell
-1,298
Closed -$203K – 415
2015
Q4 		$203K Buy
+1,298
New +$189K 0.07% 311

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advisor Partners's UTHR Position: Q2 2022 in Review

Advisor Partners increased its United Therapeutics (UTHR) stake by 8.7% in Q2 2022, buying an estimated $22.4K and bringing the position to 1,369 shares worth $323K. The position accounts for 0.02% of the portfolio, ranked #612.

Advisor Partners first reported a position in UTHR in Q4 2015 and has held it in 14 quarters since. 473 funds tracked by Wall St. Rank hold UTHR as of Q2 2022.

  • Advisor Partners held 1,369 shares of United Therapeutics worth $323K as of Q2 2022.
  • Advisor Partners bought 110 United Therapeutics shares in Q2 2022, an estimated $22.4K.
  • United Therapeutics made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #612 holding.
  • Advisor Partners first reported a position in United Therapeutics in Q4 2015 and has held it in 14 quarters since.
  • 473 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.